These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 12946560)
1. Caroverine inhibits the conditioned place aversion induced by naloxone-precipitated morphine withdrawal in rats. Kratzer U; Schmidt WJ Neurosci Lett; 2003 Oct; 349(2):91-4. PubMed ID: 12946560 [TBL] [Abstract][Full Text] [Related]
2. The anti-craving drug acamprosate inhibits the conditioned place aversion induced by naloxone-precipitated morphine withdrawal in rats. Kratzer U; Schmidt WJ Neurosci Lett; 1998 Aug; 252(1):53-6. PubMed ID: 9756357 [TBL] [Abstract][Full Text] [Related]
3. Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats. Stinus L; Cador M; Zorrilla EP; Koob GF Neuropsychopharmacology; 2005 Jan; 30(1):90-8. PubMed ID: 15138444 [TBL] [Abstract][Full Text] [Related]
4. Involvement of glutamate receptors within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats. Watanabe T; Nakagawa T; Yamamoto R; Maeda A; Minami M; Satoh M Jpn J Pharmacol; 2002 Apr; 88(4):399-406. PubMed ID: 12046982 [TBL] [Abstract][Full Text] [Related]
5. Naloxone-precipitated morphine withdrawal induced place aversions: effect of naloxone at 24 hours postmorphine. Parker LA; Joshi A Pharmacol Biochem Behav; 1998 Nov; 61(3):331-3. PubMed ID: 9768568 [TBL] [Abstract][Full Text] [Related]
6. Involvement of noradrenergic system within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats. Watanabe T; Nakagawa T; Yamamoto R; Maeda A; Minami M; Satoh M Psychopharmacology (Berl); 2003 Oct; 170(1):80-8. PubMed ID: 12768272 [TBL] [Abstract][Full Text] [Related]
7. Development, extinction and reinstatement of morphine withdrawal-induced conditioned place aversion in rats. Li Y; Liu X; Chen H; Deng H; Xiang X; Chen H; Hao W Addict Biol; 2007 Sep; 12(3-4):470-7. PubMed ID: 17678507 [TBL] [Abstract][Full Text] [Related]
8. Orexins in the midline thalamus are involved in the expression of conditioned place aversion to morphine withdrawal. Li Y; Wang H; Qi K; Chen X; Li S; Sui N; Kirouac GJ Physiol Behav; 2011 Jan; 102(1):42-50. PubMed ID: 20951152 [TBL] [Abstract][Full Text] [Related]
9. Conditioned sucrose aversions produced by naloxone-precipitated withdrawal from acutely administered morphine. McDonald RV; Parker LA; Siegel S Pharmacol Biochem Behav; 1997 Dec; 58(4):1003-8. PubMed ID: 9408206 [TBL] [Abstract][Full Text] [Related]
10. Effects of acute morphine withdrawal on ultrasonic vocalizations in adult rats: unchanged 50-kHz call rate and altered subtype profile. Lin YC; Zhao LL; Clarke PBS Psychopharmacology (Berl); 2018 Jul; 235(7):1945-1953. PubMed ID: 29663018 [TBL] [Abstract][Full Text] [Related]
11. Enkephalin release promotes homeostatic increases in constitutively active mu opioid receptors during morphine withdrawal. Shoblock JR; Maidment NT Neuroscience; 2007 Nov; 149(3):642-9. PubMed ID: 17905519 [TBL] [Abstract][Full Text] [Related]
13. Role of delta-opioid receptors in mediating the aversive stimulus effects of morphine withdrawal in the rat. Funada M; Schutz CG; Shippenberg TS Eur J Pharmacol; 1996 Apr; 300(1-2):17-24. PubMed ID: 8741160 [TBL] [Abstract][Full Text] [Related]
14. Expression of c-Fos in the rat central amygdala accompanies the acquisition but not expression of conditioned place aversion induced by withdrawal from acute morphine dependence. Jin C; Araki H; Nagata M; Shimosaka R; Shibata K; Suemaru K; Kawasaki H; Gomita Y Behav Brain Res; 2005 Jun; 161(1):107-12. PubMed ID: 15904717 [TBL] [Abstract][Full Text] [Related]
15. Reducing endocannabinoid metabolism with the fatty acid amide hydrolase inhibitor, URB597, fails to modify reinstatement of morphine-induced conditioned floor preference and naloxone-precipitated morphine withdrawal-induced conditioned floor avoidance. McCallum AL; Limebeer CL; Parker LA Pharmacol Biochem Behav; 2010 Oct; 96(4):496-500. PubMed ID: 20643159 [TBL] [Abstract][Full Text] [Related]
16. Suppression of acute and chronic opioid withdrawal by a selective soluble guanylyl cyclase inhibitor. Sullivan ME; Hall SR; Milne B; Jhamandas K Brain Res; 2000 Mar; 859(1):45-56. PubMed ID: 10720614 [TBL] [Abstract][Full Text] [Related]
17. The acute administration of the selective dopamine D(3) receptor antagonist SB-277011A reverses conditioned place aversion produced by naloxone precipitated withdrawal from acute morphine administration in rats. Rice OV; Gardner EL; Heidbreder CA; Ashby CR Synapse; 2012 Jan; 66(1):85-7. PubMed ID: 21905128 [TBL] [Abstract][Full Text] [Related]
18. Conditioned place aversion is a highly sensitive index of acute opioid dependence and withdrawal. Azar MR; Jones BC; Schulteis G Psychopharmacology (Berl); 2003 Oct; 170(1):42-50. PubMed ID: 12783156 [TBL] [Abstract][Full Text] [Related]
19. The glutamate release inhibitor riluzole attenuates the formation of conditioned place aversion induced by naloxone in rats undergoing a single morphine exposure. Jin C; Araki H; Kawasaki Y; Nagata M; Suemaru K; Shibata K; Hamamura T; Kawasaki H; Gomita Y Brain Res; 2006 Jan; 1069(1):120-6. PubMed ID: 16360647 [TBL] [Abstract][Full Text] [Related]
20. Protracted manifestations of acute dependence after a single morphine exposure. Rothwell PE; Thomas MJ; Gewirtz JC Psychopharmacology (Berl); 2012 Feb; 219(4):991-8. PubMed ID: 21833504 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]